TrialBMC cancer2015

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

Ramon Salazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.